| DAEIX | DODGX | DAEIX / DODGX | |
| Total Expense Ratio | 0.70 | 0.51 | 137% |
| Annual Report Gross Expense Ratio | 0.79 | 0.51 | 155% |
| Fund Existence | 3 years | 61 years | - |
| Gain YTD | 5.355 | 12.037 | 44% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 2500 | 40% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 84.6M | 119B | 0% |
| Annual Yield % from dividends | 2.90 | 1.32 | 219% |
| Returns for 1 year | -0.23 | 3.03 | -8% |
| Returns for 3 years | 15.50 | 29.74 | 52% |
| Returns for 5 years | N/A | 50.51 | - |
| Returns for 10 years | N/A | 83.18 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| VBK | 312.79 | 3.75 | +1.21% |
| Vanguard Small-Cap Growth ETF | |||
| DEUS | 59.15 | 0.62 | +1.06% |
| Xtrackers Russell US Multifactor ETF | |||
| IHE | 84.11 | 0.71 | +0.85% |
| iShares US Pharmaceuticals ETF | |||
| OCTM | 32.58 | 0.02 | +0.05% |
| FT Vest U.S. Equity Max Buffer ETF – Oct | |||
| SCDL | 37.75 | N/A | N/A |
| ETRACS 2x Leveraged US Div Fctr TR ETN | |||